GlassScriptPhysician profile
Mark L Skowron
NPI 1780685552
$1,813.28
in general payments reported to CMS, 2019-2025
17 companies · $76.97 in 2025
The $76.97 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $12.06 · 2021: $432 · 2022: $383 · 2023: $263 · 2024: $245 · 2025: $76.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $309.60 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $272.89 | 2023-2025 | Infuse, Miebo, Btod |
| Coopervision INC. | $226.26 | 2022-2024 | Cvi Contact Lens, Paragon Crt, Onefit Contact Lens |
| Alcon Vision LLC | $219.59 | 2021 | |
| Eyevance Pharmaceuticals LLC | $123.73 | 2022 | |
| Shire North American Group INC | $122.10 | 2019 | |
| Aerie Pharmaceuticals, INC. | $116.11 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $79.88 | 2024 | |
| Abb Con-Cise Optical Group LLC | $62.65 | 2019 | |
| Optovue, INC. | $55.91 | 2019 | |
| Abbvie INC. | $47.65 | 2022 | |
| Biotissue Holdings INC. | $36.30 | 2024 | |
| Optos, INC. | $33.34 | 2019 | |
| Sun Pharmaceutical Industries INC. | $32.19 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $28.34 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $25.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Skowron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.